Dova Keeps Mum On EU Fast-Track Request Outcome; Requests Well Down

There has been a sharp fall in the number of companies seeking accelerated assessment for their investigational products at the European Medicines Agency. One such company that has asked – Dova Pharmaceuticals – is staying silent on the outcome of its request.

airport runway under the sun as background
Drugs are reviewed faster under the EMA's accelerated assessment pathway

More from Product Reviews

More from Pink Sheet